Continue Reading With Our 7-Day Free Trial
NeoVolta Inc. (NASDAQ: NEOV) has suddenly become one of the most closely watched micro-cap names in U.S. battery storage. The NeoVolta SK On deal has become the central catalyst driving investor attention. On August 31, the company announced a five-year strategic collaboration with SK On covering as much as 18 GWh of activity between 2027 and 2031. NeoVolta shares responded sharply, rising more than 30% intraday before closing at $4.24.
The headline sounds transformational. SK On has signed an agreement to supply 9 GWh of U.S.-manufactured LFP battery cells to NeoVolta Power, NeoVolta’s majority-owned Georgia manufacturing subsidiary. The companies have also established a framework for another 9 GWh under which SK On would supply additional cells, NeoVolta Power would manufacture energy-storage packs, and SK On would purchase those packs.
But there is an important complication.
The first 9 GWh is not an order for NeoVolta products. NeoVolta is the buyer.
That distinction changes the investment debate. NeoVolta may indeed be evolving from a small residential-storage company into a meaningful U.S. BESS manufacturer. But investors need to determine how much of the 18 GWh actually becomes NeoVolta revenue, what margins it earns, and how much capital must be raised before that opportunity becomes profitable.
The NeoVolta SK On deal Is Not An 18 GWh NeoVolta Order
The first half of the SK On relationship is a signed supply agreement under which SK On will provide NeoVolta Power with 9 GWh of U.S.-manufactured LFP pouch cells from 2027 through 2031.
That is strategically important. Reliable domestic cell supply can strengthen NeoVolta’s ability to compete for utility-scale and commercial BESS contracts, particularly as developers increasingly prioritize U.S.-manufactured and FEOC-compliant equipment.
But supply is not demand.
Reuters reported that industry estimates place the value of this first agreement at approximately $1.09 billion. That figure represents the estimated value of SK On cells supplied to NeoVolta. It should not be interpreted as $1.09 billion of NeoVolta revenue.
NeoVolta still needs customers for the storage systems built around those cells. This is one of the most important distinctions investors need to make when evaluating the NeoVolta SK On deal.
The company does have one potentially significant commercial opportunity. In May, NeoVolta signed a non-binding LOI with Infinite Grid Capital covering roughly 1.1 GWh of BESS deployments associated with approximately $200 million of potential projects. But that is not yet a binding 1.1 GWh purchase order.
Investors should therefore avoid multiplying the first 9 GWh by generic BESS pricing and calling the result NeoVolta backlog.
NeoVolta itself describes the relationship as supporting up to 18 GWh of combined activity, not 18 GWh of contracted NeoVolta sales.
That wording matters.
The First 9 GWh Could Create A Working-Capital Challenge
The scale of the initial SK On agreement becomes striking when compared with NeoVolta’s current financial base.
If Reuters’ $1.09 billion industry estimate were spread evenly across the five-year term, it would imply roughly $218 million of annual cell purchases and approximately $121 per kWh.
Those figures are only illustrative. Actual annual volumes and payment schedules could differ materially.
Still, the comparison is revealing.
NeoVolta generated roughly $18 million of trailing revenue through March 2026. The estimated average annual value of SK On cell purchases would therefore be many times larger than NeoVolta’s current annual sales.
That does not mean NeoVolta must fund hundreds of millions of dollars directly with cash. Supplier credit, customer deposits, inventory financing, purchase-order financing and negotiated payment terms could reduce the working-capital burden substantially.
The problem is that those terms have not been disclosed. The financing mechanics behind the NeoVolta SK On deal could therefore become nearly as important as the headline production volumes.
Investors do not yet know whether NeoVolta must provide deposits, whether purchases contain minimum commitments, how long supplier payment terms will be, or how quickly downstream customers will pay for completed systems.
This matters because NeoVolta was already facing meaningful capital requirements before the SK On announcement. As of March 31, the company had approximately $11.5 million of cash and had consumed roughly $8.2 million of operating cash during the first nine months of fiscal 2026.
NeoVolta also invested $7 million into NeoVolta Power and previously disclosed expectations for further capital contributions toward equipment and working capital.
The Georgia manufacturing strategy therefore remains a financing story as much as an operating story.
The Second 9 GWh Is The Real Revenue Catalyst
The second half of the SK On arrangement could be far more important economically.
Under the framework, SK On would supply another 9 GWh of cells, NeoVolta Power would manufacture battery packs using those cells, and SK On would purchase the resulting packs.
That potentially gives NeoVolta something extremely valuable: an anchor customer.
If the 9 GWh were spread evenly across five years, NeoVolta would be manufacturing approximately 1.8 GWh of packs annually for SK On. That could create meaningful factory utilization and improve operating leverage at Pendergrass.
The problem is that the economics are still missing.
Investors do not yet know NeoVolta’s revenue per kWh, gross margin, minimum purchase commitments, annual volume schedule, cancellation rights or payment terms.
Applying full BESS pricing to this 9 GWh could be misleading because SK On is supplying the cells itself. NeoVolta may only capture the value associated with pack assembly, other components, engineering and manufacturing services rather than the full battery-system value.
That makes the second 9 GWh potentially transformative—but still difficult to value. For that reason, the NeoVolta SK On deal should be viewed as a major strategic opportunity rather than a fully quantified revenue backlog.
Until a definitive agreement is disclosed, investors should treat it as a major strategic opportunity rather than a fully quantified revenue backlog.
Dilution Is Already Part Of The Growth Story
NeoVolta’s share count has changed materially during 2026.
The company had approximately 42.7 million shares outstanding in mid-May. By early August, that figure had risen to approximately 58.9 million, an increase of nearly 38%.
Much of that came from a May equity raise at $2.05 per share that generated approximately $23.5 million of net proceeds. NeoVolta identified joint-venture obligations, working capital and general corporate purposes among the intended uses.
This financing was not necessarily destructive. At $4.24, the stock trades well above the May offering price. If the capital creates a profitable domestic BESS platform, issuing shares could ultimately prove accretive to enterprise value.
But it demonstrates that shareholders are already funding the expansion through dilution.
And there could be more.
NeoVolta’s filings also identify warrants, options and restricted stock units representing millions of potential additional shares. The company has also registered shares held by Infinite Grid Capital for possible resale.
The core question is therefore not just how large NeoVolta becomes.
It is how much of that future value belongs to each share when the manufacturing platform reaches scale.
What If Pendergrass Actually Reaches 8 GWh?
The strongest argument against a cautious view is that NeoVolta’s current financial statements could soon become largely irrelevant.
Management is targeting as much as 8 GWh of annual BESS production capacity at Pendergrass by 2028.
If the SK On pack framework becomes binding, Infinite Grid projects convert into actual orders, and NeoVolta wins additional third-party customers, the company could grow far beyond its current sub-$20 million revenue base. Successful conversion of the NeoVolta SK On deal would be central to that transformation.
That is the bull case.
A highly utilized domestic plant with a credible strategic supplier, anchor customer and FEOC-compliant structure could support much higher revenue and potentially much higher enterprise value.
But capacity is not utilization.
And utilization is not profitability.
The market still needs evidence of order conversion, production yields, manufacturing margins, working-capital discipline and sustainable cash generation.
Valuation & Scenario Analysis
At $4.24 per share and approximately 58.9 million shares outstanding, NeoVolta has an implied market capitalization of roughly $250 million.
Trailing revenue through March 2026 was approximately $18.1 million, implying a market-cap-to-trailing-sales multiple of about 13.8x.
That multiple cannot be justified by NeoVolta’s legacy business alone. It reflects expectations for a much larger Georgia manufacturing operation.
The valuation becomes easier to understand if revenue scales substantially:
- At $50 million of annual revenue, today’s market cap equals roughly 5.0x sales.
- At $100 million, it falls to roughly 2.5x.
- At $200 million, it falls to roughly 1.25x.
These are not forecasts or price targets. They simply illustrate how dependent the valuation is on execution.
If NeoVolta reaches several hundred million dollars of profitable revenue with manageable dilution, today’s valuation could ultimately prove attractive.
If the SK On relationship generates lower-than-expected manufacturing economics or requires significant additional capital, the current valuation leaves less room for disappointment.
What Could Go Wrong With The Cautious Thesis?
The cautious thesis could prove too conservative.
SK On is a major battery manufacturer, and its willingness to become both NeoVolta’s supplier and prospective pack customer materially strengthens the credibility of the Pendergrass platform.
The second 9 GWh arrangement could also be structured more favorably than investors currently realize. Customer-supplied cells, attractive payment terms and firm minimum volumes could reduce working-capital requirements substantially.
Securing five years of domestic cell supply could also help NeoVolta win large third-party BESS contracts that would otherwise have been inaccessible.
If Pendergrass reaches high utilization quickly, today’s trailing revenue could become a poor measure of future earnings power.
What Could Go Wrong With NeoVolta?
The risks are equally substantial.
The additional 9 GWh SK On framework has not yet been fully disclosed as a definitive purchase contract. The first 9 GWh provides supply but still requires downstream customers.
NeoVolta is also attempting a major industrial scale-up. Manufacturing gigawatt-hours of utility-scale storage involves far more complexity than selling residential systems.
Financing remains another risk. If additional equity is required, future revenue growth may be accompanied by further share-count expansion. If NeoVolta cannot fund its subsidiary obligations, its ownership interest in NeoVolta Power could also face dilution.
Finally, an 8 GWh factory only creates value if it is economically utilized.
Unused manufacturing capacity can destroy capital quickly.
Conclusion & Baptista Research View
NeoVolta’s SK On announcement is unquestionably important. The company has secured a major domestic LFP supplier and potentially a large anchor customer for its emerging Georgia manufacturing platform.
But investors should not treat 18 GWh of collaboration as 18 GWh of NeoVolta sales. That remains the central issue when assessing the NeoVolta SK On deal.
The first 9 GWh represents cells being supplied to NeoVolta. The second 9 GWh could generate meaningful manufacturing revenue, but pricing, margins, minimum volumes and payment terms remain undisclosed.
At approximately $250 million of market capitalization and roughly 13.8x trailing revenue, the market is already valuing NeoVolta on future execution rather than current earnings.
The decisive questions are therefore straightforward:
How much of the 18 GWh becomes NeoVolta revenue?
What margin does NeoVolta earn?
How much capital is required to generate it?
And how many shares will exist when the business reaches scale?
Baptista Research Rating: Underperform — High-Risk Speculative
Reference Price: $4.24 as of August 31, 2026
Approximate Equity Value: $250 million
Trailing Revenue: ~$18.1 million
Market Cap / Trailing Revenue: ~13.8x
Base-Case Target / Valuation Range: N/A
NeoVolta may have secured the supply chain for a much larger business. It has not yet shown investors exactly how much of that larger business will become profitable revenue per NEOV share.
Disclaimer: We do not hold any positions in the above stock(s). Read our full disclaimer here.
